ASTX Insider Trading Activity and SEC Form 4 Filings
ASTX insider trading summary
No open-market insider purchases or sales of Astex Pharmaceuticals, Inc (ASTX) have been reported on SEC Form 4 in the past 12 months.
Latest ASTX insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| May 14, 2013 | James S J Manuso | Chief Executive Officer | Sell | $172K (29,500 @ $5.84) |
| May 3, 2013 | Charles J Casamento | Director | Sell | $33K (5,500 @ $5.91) |
| May 3, 2013 | Charles J Casamento | Director | Sell | $384K (65,500 @ $5.87) |
| May 2, 2013 | James S J Manuso | Chief Executive Officer | Sell | $223K (38,000 @ $5.87) |
| Mar 15, 2013 | Harren Jhoti | President | Sell | $43K (10,000 @ $4.25) |
| Mar 13, 2013 | Charles J Casamento | Director | Sell | $60K (14,000 @ $4.27) |
| Mar 8, 2013 | James S J Manuso | Chief Executive Officer | Sell | $176K (40,000 @ $4.40) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.